Bio-Techne (TECH) Operating Leases (2019 - 2026)

Bio-Techne's Operating Leases history runs 8 years deep, the most recent figure standing at $76.1 million for Q1 2026.

• On a quarterly basis, Operating Leases fell 4.16% year-over-year to $76.1 million in Q1 2026; TTM through Mar 2026 was $76.1 million, a 4.16% decrease from a year earlier, with the FY2025 full-year figure at $84.0 million, down 4.17% from the prior year.
• Operating Leases declined to $76.1 million in Q1 2026 per TECH's latest filing, from $77.2 million in the prior quarter.
• Across five years, Operating Leases topped out at $97.3 million in Q3 2023 and bottomed at $56.3 million in Q1 2022.
• The 5-year median for Operating Leases is $81.6 million (2024), against an average of $81.3 million.
• Across the five-year window, Operating Leases dropped 15.67% in 2022 and surged 65.52% in 2023, its largest moves.
• Year by year, Operating Leases stood at $78.2 million in 2022, then rose by 22.82% to $96.0 million in 2023, then retreated by 15.01% to $81.6 million in 2024, then dropped by 5.43% to $77.2 million in 2025, then slipped by 1.35% to $76.1 million in 2026.
• Per Business Quant, the three latest TECH Operating Leases figures stand at $76.1 million (Q1 2026), $77.2 million (Q4 2025), and $80.7 million (Q3 2025).